Pink Sheet is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Drug Shortages: FDA Wants Advanced Warning; Practitioners Want Even More

This article was originally published in The Pink Sheet Daily

Executive Summary

Presenters at drug shortage workshop want estimates of the scope and severity of a pending supply interruption to obtain alternative therapies.
Advertisement

Related Content

User Fee Bills: After Mark-ups, How Will House And Senate Reconcile Differences?
Shortage Notification May Have Legislative Momentum Again After BIO Questions Reimbursement Fix
Obama's Drug Shortage Efforts Focus On Personnel, Persuasion
FDA's Drug Shortages Strategy Focuses On Prevention, Not "Empire Building"
Drug Shortages: Can The Blame Game Help Find Solutions?
Rx Shortages Defy Easy Solutions, FDA Notes As It Offers Congress Some Ideas
Drug Shortages Don't Lack For Attention; Sec. Sebelius Meets With Stakeholders
Drug Shortages Don't Lack For Attention; Sec. Sebelius Meets With Stakeholders
To Prevent Drug Shortages, Don't Look To Inspections, FDA Says
Drug Shortage Legislation Gains Momentum With Bipartisan House Bill

Topics

Advertisement
UsernamePublicRestriction

Register

PS072821

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel